Anne Samuel
Stock Analyst at JP Morgan
(3.51)
# 832
Out of 4,884 analysts
66
Total ratings
59.52%
Success rate
2.98%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $61.69 | -2.74% | 6 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $164.24 | +7.77% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $29.84 | +20.64% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $284.29 | -12.41% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $11.79 | +1.78% | 12 | Mar 10, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $21.46 | +7.18% | 7 | Jan 28, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $28.99 | -3.41% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $22.01 | -13.68% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $23.60 | -11.02% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $4.06 | +220.20% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $39.34 | -31.37% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $4.03 | +24.07% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $102.16 | +5.72% | 8 | Apr 2, 2024 |
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $61.69
Upside: -2.74%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $164.24
Upside: +7.77%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $29.84
Upside: +20.64%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $284.29
Upside: -12.41%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $11.79
Upside: +1.78%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $21.46
Upside: +7.18%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $28.99
Upside: -3.41%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $22.01
Upside: -13.68%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $23.60
Upside: -11.02%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $4.06
Upside: +220.20%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $39.34
Upside: -31.37%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $4.03
Upside: +24.07%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $102.16
Upside: +5.72%